NeoStem Secures Debt Facility
CNNMoney No warrants or common stock were issued in connection with this financing. “This new debt facility will serve as an excellent source of non-dilutive capital to support the launch of our Intus Phase 3 clinical trial in metastatic melanoma, a significant … |